Clinical and Immunological Characteristics of Patients with 2009 Pandemic Influenza A (H1N1) Virus Infection after Vaccination
Clinical Infectious Diseases2010Vol. 51(9), pp. 1028–1032
Citations Over TimeTop 17% of 2010 papers
Wei Liu, Sake J. de Vlas, Fang Tang, Mai‐Juan Ma, Maoti Wei, Lijuan Liu, Z. Li, Lei Zhang, Zhong‐Tao Xin, Yigang Tong, Tao Jiang, Xiao‐Ai Zhang, Cui He, Chris Li, Xiao‐Ning Xu, Hong Yang, Jan Hendrik Richardus, Wu‐Chun Cao
Abstract
Although the clinical consequences of infection are comparable between vaccinated and unvaccinated patients, humoral and cellular immune responses in vaccinated patients are boosted for some weeks, indicating an additional benefit of vaccination against 2009 pandemic influenza A (H1N1) virus.
Related Papers
- → Lack of evidence of a stable viral load set-point in early stage asymptomatic patients with chronic HIV-1 infection(1998)21 cited
- Determination of the effects of biomaterials on human peripheral blood mononuclear cells (PBMC)(2002)
- → Comparative in vitro bioactivity of cyclosporine on the proliferation of cultured peripheral blood mononuclear cells (PBMC) in sarcoidosis patients (SP) and healthy controls (HC)(2004)
- Antitumor Activity of Cord Blood Mononuclear Cells(2003)
- → Near point-of-care HIV viral load testing: Uptake and utilization in suburban Yangon, Myanmar(2022)